Retinal Blinding Disorders and Gene Therapy - Molecular and Clinical Aspects

Current Gene Therapy

Volumn 10, Issue 5, 2010, Pages 350-370

  Lorenz, Birgit ^a   Preising, Markus ^a   Stieger, Knut ^a  

^a JUSTUS LIEBIG UNIVERSITY   (Germany)

Author keywords

EOSRD; Gene therapy; LCA; Photoreceptors; Retina; Retinal degeneration; Retinitis pigmentosa; RPE

Indexed keywords

VIRUS VECTOR;

BLINDNESS; DIAGNOSTIC ACCURACY; GENE MUTATION; GENE THERAPY; GENE TRANSFER; HUMAN; PHOTORECEPTOR; PIGMENT EPITHELIUM; PREVALENCE; QUALITY OF LIFE; RETINA; RETINA DEGENERATION; REVIEW; VISION;

EID: 78651306078     PISSN: 15665232     EISSN: None     Source Type: Journal    
DOI: 10.2174/156652310793180698     Document Type: Review

References (159)

1. Hartong DT, Berson EL, Dryja TP. Retinitis pigmentosa. Lancet 2006; 368(9549): 1795-809.
2. Marigo V. Programmed cell death in retinal degeneration: targetingapoptosis in photoreceptors as potential therapy for retinal degeneration. Cell Cycle 2007; 6(6): 652-5.
3. Bennett J, Maguire AM, Cideciyan AV, et al. Stable transgeneexpression in rod photoreceptors after recombinant adenoassociatedvirus-mediated gene transfer to monkey retina. Proc Natl Acad Sci U S A 1999; 96(17): 9920-5.
4. Le Meur G, Weber M, Pereon Y, et al. Postsurgical assessment andlong-term safety of recombinant adeno-associated virus-mediatedgene transfer into the retinas of dogs and primates. Arch Ophthalmol 2005; 123(4): 500-6.
5. Weber M, Rabinowitz J, Provost N, et al. Recombinant adenoassociatedvirus serotype 4 mediates unique and exclusive longtermtransduction of retinal pigmented epithelium in rat, dog, andnonhuman primate after subretinal delivery. Mol Ther 2003; 7(6): 774-81.
6. Bainbridge JW, Smith AJ, Barker SS, et al. Effect of gene therapyon visual function in Leber's congenital amaurosis. N Engl J Med 2008 May 22; 358(21): 2231-9.
7. Cideciyan AV, Aleman TS, Boye SL, et al. Human gene therapyfor RPE65 isomerase deficiency activates the retinoid cycle of visionbut with slow rod kinetics. Proc Natl Acad Sci U S A 2008Sep 30; 105(39): 15112-7.
8. Maguire AM, Simonelli F, Pierce EA, et al. Safety and efficacy ofgene transfer for Leber's congenital amaurosis. N Engl J Med 2008May 22; 358(21): 2240-8.
9. Thompson DA, Li Y, McHenry CL, et al. Mutations in the geneencoding lecithin retinol acyltransferase are associated with earlyonsetsevere retinal dystrophy. Nat Genet 2001 Jun; 28(2): 123-4.
10. Batten ML, Imanishi Y, Maeda T, et al. Lecithin-retinol acyltransferaseis essential for accumulation of all-trans-retinyl esters in theeye and in the liver. J Biol Chem 2004; 279(11): 10422-32.
11. Lorenz B, Poliakov E, Schambeck M, Friedburg C, Preising MN, Redmond TM. A comprehensive clinical and biochemical functionalstudy of a novel RPE65 hypomorphic mutation. Invest Ophthalmol Vis Sci 2008 Dec; 49(12): 5235-42.
12. Lorenz B, Wabbels B, Wegscheider E, Hamel CP, Drexler W, Preising MN. Lack of fundus autofluorescence to 488 nanometersfrom childhood on in patients with early-onset severe retinal dystrophyassociated with mutations in RPE65. Ophthalmology 2004Aug; 111(8): 1585-94.
13. Woodruff ML, Wang Z, Chung HY, Redmond TM, Fain GL, Lem J. Spontaneous activity of opsin apoprotein is a cause of Lebercongenital amaurosis. Nat Genet 2003 Oct; 35(2): 158-64.
14. Hamann S, Schorderet DF, Cottet S. Bax-induced apoptosis inLeber's congenital amaurosis: a dual role in rod and cone degeneration. PLo S ONE 2009; 4(8): e6616.
15. Iannaccone A, Tedesco SA, Gallaher KT, Yamamoto H, Charles S, Dryja TP. Fundus albipunctatus in a 6-year old girl due to compoundheterozygous mutations in the RDH5 gene. Doc Ophthalmol 2007 Sep; 115(2): 111-6.
16. Yamamoto H, Simon A, Eriksson U, Harris E, Berson EL, Dryja TP. Mutations in the gene encoding 11-cis retinol dehydrogenasecause delayed dark adaptation and fundus albipunctatus. Nat Genet 1999 Jun; 22(2): 188-91.
17. Fishman GA, Roberts MF, Derlacki DJ, et al. Novel mutations inthe cellular retinaldehyde-binding protein gene (RLBP1) associatedwith retinitis punctata albescens: evidence of interfamilial geneticheterogeneity and fundus changes in heterozygotes. Arch Ophthalmol 2004 Jan; 122(1): 70-5.
18. Preising MN, Lorenz B. [Genetic diseases of the retinal pigmentepithelium]. Ophthalmologe 2009 Apr; 106(4): 311-9.
19. Gal A, Li Y, Thompson DA, Weir J, et al. Mutations in MERTK, the human orthologue of the RCS rat retinal dystrophy gene, causeretinitis pigmentosa. Nat Genet 2000 Nov; 26(3): 270-1.
20. Preising M, Ayuso C. Rab escort protein 1 (REP1) in intracellulartraffic: a functional and pathophysiological overview. Ophthalmic Genet 2004 Jun; 25(2): 101-10.
21. Preising MN, Wegscheider E, Friedburg C, Poloschek CM, Wabbels BK, Lorenz B. Fundus autofluorescence in carriers of choroideremiaand correlation with electrophysiologic and psychophysicaldata. Ophthalmology 2009 Jun; 116(6): 1201-9.
22. Lopez VM, Decatur CL, Stamer WD, Lynch RM, McKay BS. LDOPAis an endogenous ligand for OA1. PLo S Biol 2008 Sep 30; 6(9): e236.
23. Fischmeister R, Hartzell HC. Volume sensitivity of the bestrophinfamily of chloride channels. J Physiol 2005 Jan 15; 562(Pt 2): 477-91.
24. Marmorstein AD, Marmorstein LY, Rayborn M, Wang X, Hollyfield JG, Petrukhin K. Bestrophin, the product of the Best vitelliformmacular dystrophy gene (VMD2), localizes to the basolateralplasma membrane of the retinal pigment epithelium. Proc Natl Acad Sci U S A 2000 Nov 7; 97(23): 12758-63.
25. Marmorstein AD, Cross HE, Peachey NS. Functional roles of bestrophinsin ocular epithelia. Prog Retin Eye Res 2009 May; 28(3): 206-26.
26. Sun H, Tsunenari T, Yau KW, Nathans J. The vitelliform maculardystrophy protein defines a new family of chloride channels. Proc Natl Acad Sci U S A 2002 Mar 19; 99(6): 4008-13.
27. 2+ channels in retinal pigment epithelial cells. FASEB J 2006Jan; 20(1): 178-80.
28. Fliegauf M, Benzing T, Omran H. When cilia go bad: cilia defectsand ciliopathies. Nat Rev Mol Cell Biol 2007 Nov; 8(11): 880-93.
29. Gherman A, Davis EE, Katsanis N. The ciliary proteome database:an integrated community resource for the genetic and functionaldissection of cilia. Nat Genet 2006 Sep; 38(9): 961-2.
30. Adams NA, Awadein A, Toma HS. The retinal ciliopathies. Ophthalmic Genet 2007 Sep; 28(3): 113-25.
31. Snellman J, Kaur T, Shen Y, Nawy S. Regulation of ON bipolarcell activity. Prog Retin Eye Res 2008 Jul; 27(4): 450-63.
32. Audo I, Kohl S, Leroy BP, et al. TRPM1 is mutated in patientswith autosomal-recessive complete congenital stationary nightblindness. Am J Hum Genet 2009 Nov; 85(5): 720-9.
33. van Genderen MM, Bijveld MM, Claassen YB, et al. Mutations inTRPM1 are a common cause of complete congenital stationarynight blindness. Am J Hum Genet 2009 Nov; 85(5): 730-6.
34. Drack AV, Lambert SR, Stone EM. From the laboratory to theclinic: molecular genetic testing in pediatric ophthalmology. Am JOphthalmol 2010 Jan; 149(1): 10-7.
35. Heon E. My child has Leber congenital amaurosis: why is he/shenot eligible for gene therapy trials? J AAPOS 2009 Dec; 13(6): 533-4.
36. Koenekoop RK, Lopez I, den Hollander AI, Allikmets R, Cremers FP. Genetic testing for retinal dystrophies and dysfunctions: benefits, dilemmas and solutions. Clin Experiment Ophthalmol 2007Jul; 35(5): 473-85.
37. Pradhan M, Hayes I, Vincent A. An audit of genetic testing indiagnosis of inherited retinal disorders: a prerequisite for genespecificintervention. Clin Experiment Ophthalmol 2009 Sep; 37(7): 703-11.
38. Danciger M, Ogando D, Yang H, et al. Genetic modifiers of retinaldegeneration in the rd3 mouse. Invest Ophthalmol Vis Sci 2008Jul; 49(7): 2863-9.
39. Khanna H, Davis EE, Murga-Zamalloa CA, et al. A common allelein RPGRIP1L is a modifier of retinal degeneration in ciliopathies. Nat Genet 2009 Jun; 41(6): 739-45.
40. Samardzija M, Wenzel A, Naash M, Reme CE, Grimm C. Rpe65 asa modifier gene for inherited retinal degeneration. Eur J Neurosci 2006 Feb; 23(4): 1028-34.
41. Stone EM. Leber congenital amaurosis-A model for efficientgenetic testing of heterogeneous disorders: LXIV Edward Jackson Memorial Lecture. Am J Ophthalmol 2007 Dec; 144(6): 791-811.
42. Drack AV, Johnston R, Stone EM. Which Leber congenitalamaurosis patients are eligible for gene therapy trials? J AAPOS 2009 Oct; 13(5): 463-5.
43. Stone EM. Finding and interpreting genetic variations that areimportant to ophthalmologists. Trans Am Ophthalmol Soc 2003; 101: 437-84.
44. Philp AR, Jin M, Li S, et al. Predicting the pathogenicity of RPE65mutations. Hum Mutat 2009 Aug; 30(8): 1183-8.
45. Cideciyan AV, Swider M, Aleman TS, et al. ABCA4 disease progressionand a proposed strategy for gene therapy. Hum Mol Genet 2009 Mar 1; 18(5): 931-41.
46. Paunescu K, Preising MN, Janke B, Wissinger B, Lorenz B. Genotype-phenotype correlation in a German family with a novel complexCRX mutation extending the open reading frame. Ophthalmology 2007 Jul; 114(7): 1348-57.
47. Sharon D, Sandberg MA, Rabe VW, Stillberger M, Dryja TP, Berson EL. RP2 and RPGR mutations and clinical correlations inpatients with X-linked retinitis pigmentosa. Am J Hum Genet 2003Nov; 73(5): 1131-46.
48. Wabbels B, Preising MN, Kretschmann U, Demmler A, Lorenz B. Genotype-phenotype correlation and longitudinal course in tenfamilies with Best vitelliform macular dystrophy. Graefes Arch Clin Exp Ophthalmol 2006 Nov; 244(11): 1453-66.
49. Pang JJ, Chang B, Hawes NL, et al. Retinal degeneration 12(rd12): a new, spontaneously arising mouse model for human Lebercongenital amaurosis (LCA). Mol Vis 2005; 11: 152-62.
50. Samardzija M, von LJ, Tanimoto N, et al. R91W mutation inRpe65 leads to milder early-onset retinal dystrophy due to the generation of low levels of 11-cis-retinal. Hum Mol Genet 2008 Jan15; 17(2): 281-92.
51. Veske A, Nilsson SE, Narfstrom K, Gal A. Retinal dystrophy ofSwedish briard/briard-beagle dogs is due to a 4-bp deletion inRPE65. Genomics 1999; 57(1): 57-61.
52. Mac Laren RE. An analysis of retinal gene therapy clinical trialsCurr Opin Mol Ther 2009 Oct; 11(5): 540-6.
53. Acland GM, Aguirre GD, Bennett J, et al. Long-term restoration ofrod and cone vision by single dose rAAV-mediated gene transfer tothe retina in a canine model of childhood blindness. Mol Ther 2005; 12(6): 1072-82.
54. Vervoort R, Lennon A, Bird AC, et al. Mutational hot spot within anew RPGR exon in X-linked retinitis pigmentosa. Nat Genet 2000; 25(4): 462-6.
55. Shu X, Black GC, Rice JM, et al. RPGR mutation analysis anddisease: an update. Hum Mutat 2006; 28(4): 322-8.
56. Hong DH, Li T. Complex expression pattern of RPGR reveals arole for purine-rich exonic splicing enhancers. Invest Ophthalmol Vis Sci 2002; 43(11): 3373-82.
57. Beltran WA, Hammond P, Acland GM, Aguirre GD. A frameshiftmutation in RPGR exon ORF15 causes photoreceptor degenerationand inner retina remodeling in a model of X-linked retinitis pigmentosa. Invest Ophthalmol Vis Sci 2006; 47(4): 1669-81.
58. Hong DH, Pawlyk BS, Shang J, Sandberg MA, Berson EL, Li T. Aretinitis pigmentosa GTPase regulator (RPGR)-deficient mousemodel for X-linked retinitis pigmentosa (RP3). Proc Natl Acad Sci U S A 2000; 97(7): 3649-54.
59. Hong DH, Pawlyk BS, Adamian M, Li T. Dominant, gain-offunctionmutant produced by truncation of RPGR. Invest Ophthalmol Vis Sci 2004; 45(1): 36-41.
60. Hong DH, Pawlyk BS, Adamian M, Sandberg MA, Li T. A single, abbreviated RPGR-ORF15 variant reconstitutes RPGR function invivo. Invest Ophthalmol Vis Sci 2005; 46(2): 435-41.
61. Hong DH, Yue G, Adamian M, Li T. Retinitis pigmentosa GTPaseregulator (RPGRr)-interacting protein is stably associated with thephotoreceptor ciliary axoneme and anchors RPGR to the connectingcilium. J Biol Chem 2001; 276(15): 12091-9.
62. Zhao Y, Hong DH, Pawlyk B, et al. The retinitis pigmentosaGTPase regulator (RPGR)-interacting protein: subserving RPGRfunction and participating in disk morphogenesis. Proc Natl Acad Sci U S A 2003; 100(7): 3965-70.
63. Merbs SL, Nathans J. Absorption spectra of human cone pigments. Nature 1992 Apr 2; 356(6368): 433-5.
64. Szel A, Rohlich P, Caffe AR, Juliusson B, Aguirre G, Van VT. Unique topographic separation of two spectral classes of cones inthe mouse retina. J Comp Neurol 1992 Nov 15; 325(3): 327-42.
65. Jaissle GB, May CA, van de Pavert SA, et al. Bone spicule pigmentformation in retinitis pigmentosa: insights from a mouse model. Graefes Arch Clin Exp Ophthalmol 2010 Aug; 248(8): 1063-70.
66. Hamel CP. Cone rod dystrophies. Orphanet J Rare Dis 2007; 2: 7.
67. Michaelides M, Hardcastle AJ, Hunt DM, Moore AT. Progressivecone and cone-rod dystrophies: phenotypes and underlying moleculargenetic basis. Surv Ophthalmol 2006; 51(3): 232-58.
68. Cremers FP, van de Pol DJ, van DM, et al. Autosomal recessiveretinitis pigmentosa and cone-rod dystrophy caused by splice sitemutations in the Stargardt's disease gene ABCR. Hum Mol Genet 1998 Mar; 7(3): 355-62.
69. Wissinger B, Gamer D, Jagle H, et al. CNGA3 mutations in hereditarycone photoreceptor disorders. Am J Hum Genet 2001 Oct; 69(4): 722-37.
70. Hameed A, Abid A, Aziz A, Ismail M, Mehdi SQ, Khaliq S. Evidenceof RPGRIP1 gene mutations associated with recessive coneroddystrophy. J Med Genet 2003 Aug; 40(8): 616-9.
71. Freund CL, Gregory-Evans CY, Furukawa T, et al. Cone-rod dystrophydue to mutations in a novel photoreceptor-specific homeoboxgene (CRX) essential for maintenance of the photoreceptor. Cell 1997 Nov 14; 91(4): 543-53.
72. Kelsell RE, Gregory-Evans K, Payne AM, et al. Mutations in theretinal guanylate cyclase (RETGC-1) gene in dominant cone-roddystrophy. Hum Mol Genet 1998 Jul; 7(7): 1179-84.
73. Sohocki MM, Perrault I, Leroy BP, et al. Prevalence of AIPL1mutations in inherited retinal degenerative disease. Mol Genet Metab 2000 Jun; 70(2): 142-50.
74. Demirci FY, Rigatti BW, Wen G, et al. X-linked cone-rod dystrophy(locus COD1): identification of mutations in RPGR exonORF15. Am J Hum Genet 2002 Apr; 70(4): 1049-53.
75. Koenekoop RK. An overview of Leber congenital amaurosis: amodel to understand human retinal development. Surv Ophthalmol 2004; 49(4): 379-98.
76. Lorenz B, Gyurus P, Preising M, Bremser D, Gu S, Andrassi M, Gerth C, Gal A. Early-onset severe rod-cone dystrophy in youngchildren with RPE65 mutations. Invest Ophthalmol Vis Sci 2000; 41(9): 2735-42.
77. den Hollander AI, Roepman R, Koenekoop RK, Cremers FP. Lebercongenital amaurosis: genes, proteins and disease mechanisms. Prog Retin Eye Res 2008 Jul; 27(4): 391-419.
78. Aldahmesh MA, Al-Owain M, Alqahtani F, Hazzaa S, Alkuraya FS. A null mutation in CABP4 causes Leber's congenital amaurosis-like phenotype. Mol Vis 2010; 16: 207-12.
79. Michaelides M, Aligianis IA, Ainsworth JR, et al. Progressive conedystrophy associated with mutation in CNGB3. Invest Ophthalmol Vis Sci 2004 Jun; 45(6): 1975-82.
80. Thiadens AA, den Hollander AI, Roosing S, et al. Homozygositymapping reveals PDE6C mutations in patients with early-onsetcone photoreceptor disorders. Am J Hum Genet 2009 Aug; 85(2): 240-7.
81. Kramer F, White K, Pauleikhoff D, et al. Mutations in the VMD2gene are associated with juvenile-onset vitelliform macular dystrophy(Best disease) and adult vitelliform macular dystrophy but notage-related macular degeneration. Eur J Hum Genet 2000 Apr; 8(4): 286-92.
82. Boon CJ, Klevering BJ, Leroy BP, Hoyng CB, Keunen JE, denHollander AI. The spectrum of ocular phenotypes caused by mutationsin the BEST1 gene. Prog Retin Eye Res 2009 May; 28(3): 187-205.
83. Burgess R, Millar ID, Leroy BP, et al. Biallelic mutation of BEST1causes a distinct retinopathy in humans. Am J Hum Genet 2008Jan; 82(1): 19-31.
84. Gerth C, Zawadzki RJ, Werner JS, Heon E. Detailed analysis ofretinal function and morphology in a patient with autosomal recessivebestrophinopathy (ARB). Doc Ophthalmol 2009 Jun; 118(3): 239-46.
85. Davidson AE, Millar ID, Urquhart JE, et al. Missense mutations ina retinal pigment epithelium protein, bestrophin-1, cause retinitispigmentosa. Am J Hum Genet 2009 Nov; 85(5): 581-92.
86. Fishman GA, Stone EM, Eliason DA, Taylor CM, Lindeman M, Derlacki DJ. ABCA4 gene sequence variations in patients withautosomal recessive cone-rod dystrophy. Arch Ophthalmol 2003Jun; 121(6): 851-5.
87. Genead MA, Fishman GA, Stone EM, Allikmets R. The naturalhistory of stargardt disease with specific sequence mutation in theABCA4 gene. Invest Ophthalmol Vis Sci 2009 Dec; 50(12): 5867-71.
88. Gerth C, ndrassi-Darida M, Bock M, Preising MN, Weber BH, Lorenz B. Phenotypes of 16 Stargardt macular dystrophy/fundusflavimaculatus patients with known ABCA4 mutations and evaluationof genotype-phenotype correlation. Graefes Arch Clin Exp Ophthalmol 2002 Aug; 240(8): 628-38.
89. Lorenz B, Preising MN. Age matters--thoughts on a grading systemfor ABCA4 mutations. Graefes Arch Clin Exp Ophthalmol 2005Feb; 243(2): 87-9.
90. Allikmets R, Shroyer NF, Singh N, et al. Mutation of the Stargardtdisease gene (ABCR) in age-related macular degeneration. Science 1997; 277(5333): 1805-7.
91. Martinez-Mir A, Paloma E, Allikmets R, et al. Retinitis pigmentosacaused by a homozygous mutation in the Stargardt disease geneABCR. Nat Genet 1998 Jan; 18(1): 11-2.
92. Molday LL, Rabin AR, Molday RS. ABCR expression in fovealcone photoreceptors and its role in Stargardt macular dystrophy. Nat Genet 2000 Jul; 25(3): 257-8.
93. Sun H, Nathans J. Stargardt's ABCR is localized to the disc membraneof retinal rod outer segments. Nat Genet 1997 Sep; 17(1): 15-6.
94. Cideciyan AV, Aleman TS, Swider M, et al. Mutations in ABCA4result in accumulation of lipofuscin before slowing of the retinoidcycle: a reappraisal of the human disease sequence. Hum Mol Genet 2004 Mar 1; 13(5): 525-34.
95. Weng J, Mata NL, Azarian SM, Tzekov RT, Birch DG, Travis GH. Insights into the function of Rim protein in photoreceptors and etiologyof Stargardt's disease from the phenotype in abcr knockoutmice. Cell 1999 Jul 9; 98(1): 13-23.
96. Allikmets R, Wasserman WW, Hutchinson A, et al. Organizationof the ABCR gene: analysis of promoter and splice junction sequences. Gene 1998 Jul 17; 215(1): 111-22.
97. Thiadens AA, Slingerland NW, Roosing S, et al. Genetic etiologyand clinical consequences of complete and incomplete achromatopsia. Ophthalmology 2009 Oct; 116(10): 1984-9.
98. Michaelides M, Hunt DM, Moore AT. The cone dysfunction syndromes. Br J Ophthalmol 2004 Feb; 88(2): 291-7.
99. Kohl S. [Genetic causes of hereditary cone and cone-rod dystrophies]. Ophthalmologe 2009 Feb; 106(2): 109-15.
100. Kohl S, Marx T, Giddings I, et al. Total colourblindness is causedby mutations in the gene encoding the alpha-subunit of the conephotoreceptor cGMP-gated cation channel. Nat Genet 1998 Jul; 19(3): 257-9.
101. Kohl S, Baumann B, Broghammer M, et al. Mutations in theCNGB3 gene encoding the beta-subunit of the cone photoreceptorcGMP-gated channel are responsible for achromatopsia (ACHM3)linked to chromosome 8q21. Hum Mol Genet 2000 Sep 1; 9(14): 2107-16.
102. Kohl S, Baumann B, Rosenberg T, et al. Mutations in the conephotoreceptor G-protein alpha-subunit gene GNAT2 in patientswith achromatopsia. Am J Hum Genet 2002 Aug; 71(2): 422-5.
103. Bech-Hansen NT, Naylor MJ, Maybaum TA, et al. Mutations inNYX, encoding the leucine-rich proteoglycan nyctalopin, cause Xlinkedcomplete congenital stationary night blindness. Nat Genet 2000 Nov; 26(3): 319-23.
104. Dryja TP, McGee TL, Berson EL, et al. Night blindness and abnormalcone electroretinogram ON responses in patients with mutationsin the GRM6 gene encoding mGlu R6. Proc Natl Acad Sci US A 2005 Mar 29; 102(13): 4884-9.
105. Zeitz C, van GM, Neidhardt J, et al. Mutations in GRM6 causeautosomal recessive congenital stationary night blindness with adistinctive scotopic 15-Hz flicker electroretinogram. Invest Ophthalmol Vis Sci 2005 Nov; 46(11): 4328-35.
106. Zeitz C, Forster U, Neidhardt J, et al. Night blindness-associatedmutations in the ligand-binding, cysteine-rich, and intracellulardomains of the metabotropic glutamate receptor 6 abolish proteintrafficking. Hum Mutat 2007 Aug; 28(8): 771-80.
107. Bech-Hansen NT, Naylor MJ, Maybaum TA, et al. Loss-offunctionmutations in a calcium-channel alpha1-subunit gene inXp11.23 cause incomplete X-linked congenital stationary nightblindness. Nat Genet 1998 Jul; 19(3): 264-7.
108. 2+-binding protein 4, cause autosomal recessive night blindness. Am J Hum Genet 2006Oct; 79(4): 657-67.
109. Wycisk KA, Zeitz C, Feil S, et al. Mutation in the auxiliary calcium-channel subunit CACNA2D4 causes autosomal recessivecone dystrophy. Am J Hum Genet 2006 Nov; 79(5): 973-7.
110. Sikkink SK, Biswas S, Parry NR, Stanga PE, Trump D. X-linkedretinoschisis: an update. J Med Genet 2007 Apr; 44(4): 225-32.
111. Wabbels B, Demmler A, Paunescu K, Wegscheider E, Preising MN, Lorenz B. Fundus autofluorescence in children and teenagerswith hereditary retinal diseases. Graefes Arch Clin Exp Ophthalmol 2006 Jan; 244(1): 36-45.
112. Renner AB, Kellner U, Fiebig B, Cropp E, Foerster MH, Weber BH. ERG variability in X-linked congenital retinoschisis patientswith mutations in the RS1 gene and the diagnostic importance offundus autofluorescence and OCT. Doc Ophthalmol 2008 Mar; 116(2): 97-109.
113. Khan NW, Jamison JA, Kemp JA, Sieving PA. Analysis of photoreceptorfunction and inner retinal activity in juvenile X-linkedretinoschisis. Vision Res 2001 Dec; 41(28): 3931-42.
114. Gehrig A, Weber BH, Lorenz B, Andrassi M. First molecular evidencefor a de novo mutation in RS1 (XLRS1) associated with Xlinked juvenile retinoschisis. J Med Genet 1999 Dec; 36(12): 932-4.
115. Sauer CG, Gehrig A, Warneke-Wittstock R, et al. Positional cloningof the gene associated with X-linked juvenile retinoschisis. Nat Genet 1997 Oct; 17(2): 164-70.
116. Molday LL, Min SH, Seeliger MW, et al. Disease mechanisms andgene therapy in a mouse model for X-linked retinoschisis. Adv Exp Med Biol 2006; 572: 283-9.
117. Takada Y, Vijayasarathy C, Zeng Y, Kjellstrom S, Bush RA, Sieving PA. Synaptic pathology in retinoschisis knockout (Rs1-/y)mouse retina and modification by rAAV-Rs1 gene delivery. Invest Ophthalmol Vis Sci 2008 Aug; 49(8): 3677-86.
118. Preising M, Op de Laak JP, Lorenz B. Deletion in the OA1 gene ina family with congenital X linked nystagmus. Br J Ophthalmol 2001 Sep; 85(9): 1098-103.
119. Bassi MT, Schiaffino MV, Renieri A, et al. Cloning of the gene forocular albinism type 1 from the distal short arm of the X chromosome. Nat Genet 1995 May; 10(1): 13-9.
120. Rosenberg T, Schwartz M. X-linked ocular albinism: prevalenceand mutations--a national study. Eur J Hum Genet 1998 Nov; 6(6): 570-7.
121. Hoffmann MB, Lorenz B, Morland AB, Schmidtborn LC. Misroutingof the optic nerves in albinism: estimation of the extentwith visual evoked potentials. Invest Ophthalmol Vis Sci 2005 Oct; 46(10): 3892-8.
122. Hoffmann MB, Lorenz B, Preising M, Seufert PS. Assessment ofcortical visual field representations with multifocal VEPs in controlsubjects, patients with albinism, and female carriers of ocular albinism. Invest Ophthalmol Vis Sci 2006 Jul; 47(7): 3195-201.
123. Oetting WS, King RA. Molecular basis of type I (tyrosinaserelated)oculocutaneous albinism: mutations and polymorphisms ofthe human tyrosinase gene. Hum Mutat 1993; 2(1): 1-6.
124. Oetting WS, Gardner JM, Fryer JP, et al. Mutations of the human Pgene associated with Type II oculocutaneous albinism (OCA2). Mutations in brief no. 205. Online. Hum Mutat 1998; 12(6): 434.
125. King RA, Pietsch J, Fryer JP, et al. Tyrosinase gene mutations inoculocutaneous albinism 1 (OCA1): definition of the phenotype. Hum Genet 2003 Nov; 113(6): 502-13.
126. Preising MN, Forster H, Tan H, Lorenz B, de Jong PT, Plomp AS. Mutation analysis in a family with oculocutaneous albinism manifestingin the same generation of three branches. Mol Vis 2007; 13: 1851-5.
127. Kerr R, Stevens G, Manga P, et al. Identification of P gene mutationsin individuals with oculocutaneous albinism in sub-Saharan Africa. Hum Mutat 2000; 15(2): 166-72.
128. Kubal A, Dagnelie G, Goldberg M. Ocular albinism with absentfoveal pits but without nystagmus, photophobia, or severely reducedvision. J AAPOS 2009 Dec; 13(6): 610-2.
129. Cremers FP, van de Pol DJ, van Kerkhoff LP, Wieringa B, Ropers HH. Cloning of a gene that is rearranged in patients with choroideraemia. Nature 1990 Oct 18; 347(6294): 674-7.
130. Rudolph G, Preising M, Kalpadakis P, Haritoglou C, Lang GE, Lorenz B. Phenotypic variability in three carriers from a familywith choroideremia and a frameshift mutation 1388delCCins G inthe REP-1 gene. Ophthalmic Genet 2003 Dec; 24(4): 203-14.
131. Renner AB, Fiebig BS, Cropp E, Weber BH, Kellner U. Progressionof retinal pigment epithelial alterations during long-term follow-up in female carriers of choroideremia and report of a novelCHM mutation. Arch Ophthalmol 2009 Jul; 127(7): 907-12.
132. Cremers FP, Sankila EM, Brunsmann F, et al. Deletions in patientswith classical choroideremia vary in size from 45 kb to severalmegabases. Am J Hum Genet 1990 Oct; 47(4): 622-8.
133. Hildebrandt F, Zhou W. Nephronophthisis-associated ciliopathies. J Am Soc Nephrol 2007 Jun; 18(6): 1855-71.
134. Littink KW, Pott JW, Collin RW, et al. A novel nonsense mutationin CEP290 induces exon skipping and leads to a relatively mildretinal phenotype. Invest Ophthalmol Vis Sci 2010 Feb 3.
135. Louie CM, Caridi G, Lopes VS, et al. AHI1 is required for photoreceptorouter segment development and is a modifier for retinaldegeneration in nephronophthisis. Nat Genet 2010 Feb; 42(2): 175-80.
136. Paunescu K, Wabbels B, Preising MN, Lorenz B. Longitudinal andcross-sectional study of patients with early-onset severe retinal dystrophyassociated with RPE65 mutations. Graefes Arch Clin Exp Ophthalmol 2005 May; 243(5): 417-26.
137. Walia S, Fishman GA, Swaroop A, et al. Discordant phenotypes infraternal twins having an identical mutation in exon ORF15 of theRPGR gene. Arch Ophthalmol 2008 Mar; 126(3): 379-84.
138. Lois N, Halfyard AS, Bird AC, Holder GE, Fitzke FW. Fundusautofluorescence in Stargardt macular dystrophy-fundus flavimaculatus. Am J Ophthalmol 2004 Jul; 138(1): 55-63.
139. Lois N, Holder GE, Bunce C, Fitzke FW, Bird AC. Phenotypicsubtypes of Stargardt macular dystrophy-fundus flavimaculatus. Arch Ophthalmol 2001 Mar; 119(3): 359-69.
140. Jacobson SG, Cideciyan AV, Aleman TS, et al. Photoreceptor layertopography in children with leber congenital amaurosis caused byRPE65 mutations. Invest Ophthalmol Vis Sci 2008 Oct; 49(10): 4573-7.
141. Jacobson SG, Aleman TS, Cideciyan AV, et al. Defining the residualvision in leber congenital amaurosis caused by RPE65 mutations. Invest Ophthalmol Vis Sci 2009 May; 50(5): 2368-75.
142. Pasadhika S, Fishman GA, Stone EM, et al. Differential macularmorphology in patients with RPE65, CEP290, GUCY2D andAIPL1 related leber congenital amaurosis. Invest Ophthalmol Vis Sci 2009 Dec 3.
143. Jacobson SG, Cideciyan AV, Aleman TS, et al. Crumbs homolog 1(CRB1) mutations result in a thick human retina with abnormallamination. Hum Mol Genet 2003 May 1; 12(9): 1073-8.
144. Walia S, Fishman GA, Jacobson SG, et al. Visual Acuity in Patientswith Leber's Congenital Amaurosis and Early Childhood-Onset Retinitis Pigmentosa. Ophthalmology 2010 Jan 14.
145. Wegscheider E, Preising MN, Lorenz B. Fundus autofluorescencein carriers of X-linked recessive retinitis pigmentosa associatedwith mutations in RPGR, and correlation with electrophysiologicaland psychophysical data. Graefes Arch Clin Exp Ophthalmol 2004Jun; 242(6): 501-11.
146. Jacobson SG, Voigt WJ, Parel JM, et al. Automated light-anddark-adapted perimetry for evaluating retinitis pigmentosa. Ophthalmology 1986 Dec; 93(12): 1604-11.
147. Kardon R, Anderson SC, Damarjian TG, Grace EM, Stone E, Kawasaki A. Chromatic pupil responses: preferential activation of themelanopsin-mediated versus outer photoreceptor-mediated pupillight reflex. Ophthalmology 2009 Aug; 116(8): 1564-73.
148. Jacobson SG, Buraczynska M, Milam AH, et al. Disease expressionin X-linked retinitis pigmentosa caused by a putative null mutationin the RPGR gene. Invest Ophthalmol Vis Sci 1997 Sep; 38(10): 1983-97.
149. Lorenz B, Andrassi M, Kretschmann U. Phenotype in two familieswith RP3 associated with RPGR mutations. Ophthalmic Genet 2003 Jun; 24(2): 89-101.
150. Michaelides M, Holder GE, Hunt DM, Fitzke FW, Bird AC, Moore AT. A detailed study of the phenotype of an autosomal dominantcone-rod dystrophy (CORD7) associated with mutation in the genefor RIM1. Br J Ophthalmol 2005 Feb; 89(2): 198-206.
151. Evans K, Duvall-Young J, Fitzke FW, Arden GB, Bhattacharya SS, Bird AC. Chromosome 19q cone-rod retinal dystrophy. Ocularphenotype. Arch Ophthalmol 1995 Feb; 113(2): 195-201.
152. Roman AJ, Schwartz SB, Aleman TS, et al. Quantifying rod photoreceptor-mediated vision in retinal degenerations: dark-adaptedthresholds as outcome measures. Exp Eye Res 2005 Feb; 80(2): 259-72.
153. Roman AJ, Cideciyan AV, Aleman TS, Jacobson SG. Full-fieldstimulus testing (FST) to quantify visual perception in severelyblind candidates for treatment trials. Physiol Meas 2007 Aug; 28(8): N51-N56.
154. Rohrschneider K, Bultmann S, Springer C. Use of fundus perimetry(microperimetry) to quantify macular sensitivity. Prog Retin Eye Res 2008 Sep; 27(5): 536-48.
155. Fletcher DC, Schuchard RA. Preferred retinal loci relationship tomacular scotomas in a low-vision population. Ophthalmology 1997Apr; 104(4): 632-8.
156. Cideciyan AV, Hauswirth WW, Aleman TS, et al. Vision 1 yearafter gene therapy for Leber's congenital amaurosis. N Engl J Med 2009 Aug 13; 361(7): 725-7.
157. Smith AJ, Schlichtenbrede FC, Tschernutter M, Bainbridge JW, Thrasher AJ, Ali RR. AAV-Mediated gene transfer slows photoreceptorloss in the RCS rat model of retinitis pigmentosa. Mol Ther 2003; 8(2): 188-95.
158. Bi A, Cui J, Ma YP, Olshevskaya E, Pu M, Dizhoor AM, Pan ZH. Ectopic expression of a microbial-type rhodopsin restores visual responsesin mice with photoreceptor degeneration. Neuron 2006; 50(1): 23-33.
159. Buch PK, Mac LAren RE, Ali RR. Neuroprotective Gene Therapyfor the Treatment of Inherited Retinal Degeneration. Curr Gene Ther 2007; 7(6): 434-445